We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual ... Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a pipeline of therapeutic assets targeting oncology indications. It also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin resistant endometrial cancer. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.253 | 6.24691358025 | 4.05 | 4.32 | 3.97 | 10855 | 4.21482899 | CS |
4 | 0.023 | 0.53738317757 | 4.28 | 4.4331 | 3.9 | 15579 | 4.2029216 | CS |
12 | 0.613 | 16.6124661247 | 3.69 | 4.65 | 3.5601 | 23251 | 4.03660471 | CS |
26 | 0.303 | 7.575 | 4 | 5.2 | 2.78 | 19535 | 3.98184157 | CS |
52 | 0.623 | 16.9293478261 | 3.68 | 5.2 | 2.78 | 12549 | 3.9876062 | CS |
156 | -8.197 | -65.576 | 12.5 | 13 | 2.40101 | 47359 | 7.12228986 | CS |
260 | -10.997 | -71.8758169935 | 15.3 | 56.8 | 2.40101 | 686462 | 27.11575977 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions